parkinson, Parkinson's research notebook

Six readers

reader	found	score
genetics Open Targets	no genetic evidence; overall 0.01 from other evidence	0.00
cell type Human Protein Atlas	cell type enhanced, including microglia; strongest in neutrophils	0.75
chemistry Open Targets	a small-molecule pocket	0.60
trials ClinicalTrials.gov	no Parkinson's trials on record: an open field	1.00
literature PubMed	2 Parkinson's papers of 293	0.85
pathways Reactome	1 pathway; mostly other	0.30

No case: the score is under the bar. Receipt 11180

receipt 11188: CD53 in dopamine neurons, braak

power: full sample -0.23 (p 0.365, n 18), 95% CI -0.63 to +0.27. the interval is wide: not enough donors to tell.
confounder: adjusted for sex: -0.25 (p 0.315, n 18). does not hold up.
composition: dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.24 (p 0.341, n 18). could be the mix.
skeptic: leave-one-out range -0.34 to -0.11, sign flips 0; without severely affected donors -0.23 (p 0.365, n 18). fragile.
cell type: no other cell group does better.
axis: no measure beats "tracks Braak Lewy-body stage" for CD53 in dopamine neurons.

case closed: nothing better to follow up.

receipt 11187: CD53 in microglia, braak

power: full sample -0.01 (p 0.956, n 18), 95% CI -0.48 to +0.46. the interval is wide: not enough donors to tell.
confounder: adjusted for sex: -0.08 (p 0.741, n 18). does not hold up.
composition: microglia share of nuclei vs axis -0.11 (p 0.652); controlling for it: +0.04 (p 0.867, n 18). could be the mix.
skeptic: leave-one-out range -0.11 to +0.13, sign flips 6; without severely affected donors -0.01 (p 0.956, n 18). fragile.
cell type: no other cell group does better.
axis: no measure beats "tracks Braak Lewy-body stage" for CD53 in microglia.

case closed: nothing better to follow up.

loading the receipts